Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Hoth Therapeutics ( (HOTH) ) is now available.
On April 30, 2026, Hoth Therapeutics received notice from Nasdaq that it was no longer in compliance with the exchange’s $1.00 minimum bid price requirement, after its stock closed below that threshold for 30 consecutive business days between March 18 and April 29, 2026. The notification does not immediately affect trading, but the company has until October 27, 2026, with a possible additional 180-day extension, to restore its share price to at least $1.00 for 10 straight business days or face potential delisting, and it is monitoring its stock and considering options such as a reverse split to preserve its Nasdaq listing.
More about Hoth Therapeutics
Hoth Therapeutics, Inc. is a biopharmaceutical company focused on developing therapeutic treatments, with its common stock listed on The Nasdaq Capital Market under the symbol HOTH. The company’s shares are subject to Nasdaq’s continued listing standards, including minimum bid price requirements that are critical for maintaining its access to a major public equity market.
Average Trading Volume: 2,703,091
Technical Sentiment Signal: Sell
Current Market Cap: $13.98M
For an in-depth examination of HOTH stock, go to TipRanks’ Overview page.